The primary defect which leads to sickle cell anemia is:
In the context of human hemoglobin function, which of the following factors is most critical to be conserved among its variants?
Activated protein C inhibits the clotting mechanism by inactivating which of the following clotting factors?
Iron metabolism and regulation are important for RBC precursor cells. Which of the following helps in the regulation of iron metabolism but is not specific for iron?
What is the normal saturation percentage of transferrin with iron?
How many heme groups are present in a hemoglobin molecule?
Which substance is conjugated in the liver and is the final product of heme catabolism?
What is the formula for calculating transferrin saturation?
Which of the following substances inhibits the absorption of inorganic iron?
How many Fe²⁺ atoms are present in one molecule of hemoglobin (Hb)?
Explanation: ***Replacement of glutamate by valine in β-chain of HbA*** - The primary defect in sickle cell anemia is a **point mutation** that leads to the replacement of **glutamic acid** with **valine** in the **sixth position** of the β-globin chain [1]. - This mutation causes the hemoglobin (HbS) to polymerize under low oxygen conditions, resulting in the characteristic **sickle-shaped red blood cells** [1]. *A nonsence mutation in the I3-chain of HbA* - A nonsense mutation leads to a **premature stop codon**, which is not the mechanism behind sickle cell anemia. - This mutation does not involve the β-globin chain, which is critical in this specific disorder. *Substitution of valine by glutamate in the a-chain of HbA* - This statement is incorrect as sickle cell anemia specifically involves the **β-chain**, not the **α-chain**. - Substituting valine with glutamate does not cause sickling but rather the opposite of the actual defect observed in this condition. *An abnormality in porphyrin part of hemoglobin* - Sickle cell anemia does not arise from **porphyrin metabolism issues**, which are related to conditions like **porphyrias**. - The primary defect is a change in the amino acid sequence, not in the porphyrin structure of hemoglobin. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 598-599.
Explanation: **Ligand binding residues** - The **ligand binding residues** within the heme pocket are crucial for hemoglobin's primary function of reversible oxygen binding and transport. - Even minor alterations in these critical residues can severely impair oxygen affinity and delivery, leading to clinical conditions such as **hemoglobinopathies**. *Amino acid sequence* - While the overall amino acid sequence is important for protein structure, variations can exist (e.g., in different hemoglobin subunits or species) without compromising function. - Certain amino acid substitutions, especially those not at the active site, might be tolerated or even beneficial. *Overall protein structure* - The overall **quaternary and tertiary structure** is vital for cooperativity and allosteric regulation but is often robust to minor sequence changes. - Maintenance of the 3D structure is a consequence of the sequence, but direct conservation of the entire structure is less critical than the active site. *Environmental factors* - Environmental factors such as pH, temperature, and 2,3-BPG concentration **modulate** hemoglobin function but are not intrinsic parts of the hemoglobin molecule itself. - While important for physiological regulation, they are external influences rather than conserved structural elements within the protein.
Explanation: ***Factor Va and Factor VIIIa*** - **Activated protein C (APC)** functions as a natural anticoagulant by specifically inactivating the activated forms of **Factor V (Va)** and **Factor VIII (VIIIa)**. - By inactivating these cofactors, APC effectively downregulates the functioning of the **prothrombinase complex** and **tenase complex**, thereby slowing down thrombin generation and subsequent fibrin formation. *Factor III and Factor VIIIa* - **Factor III (tissue factor)** initiates the extrinsic coagulation pathway, but it is not directly inactivated by activated protein C. - While **Factor VIIIa** is a target of APC, the combination with Factor III makes this option incorrect. *Factor VIIIa and Factor IX* - **Factor VIIIa** is indeed inactivated by APC. - However, **Factor IX** (the inactive zymogen) and its activated form **Factor IXa** are not direct targets for inactivation by APC; Factor IXa remains active to participate in the tenase complex until its co-factor Factor VIIIa is inactivated. *Factor Va and Factor VII* - **Factor Va** is a known target for inactivation by APC. - **Factor VII** (the inactive zymogen) and its activated form **Factor VIIa** are not inactivated by APC; Factor VIIa plays a role in the initiation of coagulation by forming a complex with tissue factor.
Explanation: ***DMT-1*** - **DMT-1** (Divalent Metal Transporter 1) facilitates the transport of not only **iron** but also other divalent metals, making it essential for overall metal homeostasis. - It plays a role in the absorption of iron from the **intestine** and release from macrophages, influencing iron availability indirectly. *Hepcidin* - Hepcidin is a **specific** regulator of iron metabolism [2][4], controlling iron absorption and distribution but primarily for **iron regulation**. - It acts defensively against iron overload by inhibiting **ferroportin** [2], specifically targeting iron metabolism. *Ferritin* - Ferritin primarily serves as an **iron storage** protein [1], sequestering excess iron but not involved in its regulatory mechanism in the same context. - It indicates iron levels in the body but does not actively regulate iron metabolism. *Ferroportin* - Ferroportin is an **iron exporter** that helps in the release of iron from cells, particularly in macrophages and enterocytes [2][3], directly linked to iron metabolism regulation. - However, it is **specific for iron** and does not facilitate a broader regulation of other divalent metals. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 658. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 658-659. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 657-658. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 854.
Explanation: ***35%*** - A normal transferrin saturation is typically around **20% to 50%**, with **35%** being an average value indicating adequate iron binding capacity [1]. - This saturation gives an indication of the availability of iron for erythropoiesis and reflects the body's **iron stores**. *70%* - A saturation of **70%** would indicate **excessive iron** accumulation, suggestive of conditions like **hemochromatosis**. - Normal ranges do not exceed **55%**, making this option inaccurate for normal physiology. *50%* - While **50%** can still fall within borderline normal limits, it is on the higher end and might suggest **increased iron loading** if consistently elevated. - Normal transferrin saturation is generally described as being lower than this level in healthy individuals [1]. *20%* - A saturation of **20%** is on the lower spectrum but could indicate **iron deficiency**, which is not considered normal. - While still potentially acceptable, it is lower than what is generally defined as a normal average transferrin saturation. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 657-658.
Explanation: ***4*** - A **hemoglobin molecule** is composed of **four polypeptide chains** (typically two alpha and two beta subunits). - Each of these four polypeptide chains contains **one heme group**, making a total of **four heme groups per hemoglobin molecule**. - The quaternary structure of hemoglobin as a **tetramer** allows it to efficiently bind and transport oxygen. *1* - This number represents the heme groups found in a single **myoglobin molecule**, which is a monomeric protein with only one polypeptide chain. - Hemoglobin, however, is a **tetramer** with four subunits, each containing one heme group. *2* - This number is incorrect and does not correspond to the structure of hemoglobin. - Hemoglobin requires **four heme groups** (one per subunit) to function efficiently as an oxygen transporter with cooperative binding. *3* - This number is incorrect; the symmetrical quaternary structure of hemoglobin consists of **four subunits**, not three. - Each subunit contains one heme group as a prosthetic group, resulting in a total of four heme groups per hemoglobin molecule.
Explanation: ***Bilirubin*** - **Bilirubin** is the primary end-product of **heme catabolism**, which largely occurs in the body's reticuloendothelial system (e.g., spleen, liver). - Unconjugated bilirubin is transported to the **liver**, where it undergoes **conjugation** with glucuronic acid, making it water-soluble for excretion in bile. *Myoglobin* - **Myoglobin** is an oxygen-binding protein found in **muscle cells**, similar to hemoglobin in red blood cells. - While it contains a heme group, it is not a direct product of heme catabolism in the same way bilirubin is, but rather a separate functional protein. *Hemoglobin* - **Hemoglobin** is the protein in red blood cells responsible for **oxygen transport**, and it contains four heme groups. - While heme is derived from hemoglobin breakdown, hemoglobin itself is the precursor to heme catabolism, not the catabolic product. *Biliverdin* - **Biliverdin** is an **intermediate product** in the catabolism of heme, formed directly from heme by the enzyme **heme oxygenase**. - It is rapidly reduced to bilirubin by **biliverdin reductase**, making bilirubin the primary end-product that undergoes further processing in the liver.
Explanation: ***Correct: Serum iron divided by TIBC multiplied by 100*** - **Transferrin saturation (TSAT)** is calculated by dividing the **serum iron** concentration by the **total iron-binding capacity (TIBC)** and multiplying by 100 to express it as a percentage. - This formula directly reflects the percentage of **iron-binding sites on transferrin** that are occupied by iron. - **Formula: TSAT % = (Serum Iron ÷ TIBC) × 100** - **Normal range: 20-50%** *Incorrect: TIBC divided by serum iron multiplied by 100* - This formula provides the **reciprocal of transferrin saturation**, which does not represent the percentage of occupied binding sites. - It would indicate how many times the **TIBC** is greater than the **serum iron**, which is not a standard iron status measure. *Incorrect: TIBC divided by serum iron* - This non-percentage form represents the ratio of **total iron-binding capacity** to **serum iron**, which is the inverse of transferrin saturation. - It does not give a direct percentage of **transferrin saturation**. *Incorrect: Serum iron divided by TIBC* - This formula provides the **fraction of transferrin saturation** but does not express it as a percentage. - Multiplying by 100 is necessary to convert this fraction into a clinically useful percentage value.
Explanation: ***Calcium*** - **Calcium** and **iron** compete for absorption pathways in the intestines, particularly when calcium is administered in large amounts. - High intake of **dairy products** or **calcium supplements** can significantly reduce the absorption of non-heme iron. *Alcohol* - **Alcohol** generally enhances **iron absorption**, especially in individuals with **hereditary hemochromatosis**, due to effects on the intestinal lining. - It does not inhibit inorganic iron absorption, and chronic alcoholics can sometimes develop **iron overload**. *Fructose* - **Fructose** does not significantly inhibit the absorption of **inorganic iron**; in fact, some studies suggest it may slightly enhance iron bioavailability. - Its primary role in carbohydrate metabolism does not directly interfere with iron uptake mechanisms. *Vitamin C* - **Vitamin C** (ascorbic acid) is a powerful enhancer of **non-heme iron absorption** by reducing ferric iron (Fe3+) to the more soluble and absorbable ferrous iron (Fe2+). - It actively promotes, rather than inhibits, inorganic iron uptake.
Explanation: ***Four Fe²⁺ atoms*** - A single molecule of **hemoglobin** is composed of **four globin chains**, each containing one **heme group**. - Each **heme group** in hemoglobin contains one central **ferrous iron (Fe²⁺) atom**, allowing for the binding of one oxygen molecule per heme group. *One Fe²⁺ atom* - This is incorrect because hemoglobin is a **tetramer**, meaning it has multiple subunits. - Only one heme group (and thus one Fe²⁺ atom) is present in **myoglobin**, which is a single polypeptide chain, not hemoglobin. *Two Fe²⁺ atoms* - This is incorrect as it does not account for the **tetrameric structure** of adult hemoglobin. - While some developmental forms of hemoglobin could be considered to have two alpha and two beta chains, each still has its own heme group. *Eight Fe²⁺ atoms* - This is incorrect as it would imply two Fe²⁺ atoms per heme group or multiple heme groups per globin chain. - The 1:1 ratio of heme group to Fe²⁺ atom and globin chain to heme group is fundamental to hemoglobin structure.
Hemoglobin Structure and Function
Practice Questions
Oxygen Transport and Oxygen-Hemoglobin Dissociation Curve
Practice Questions
Hemoglobin Variants and Hemoglobinopathies
Practice Questions
Thalassemias
Practice Questions
Methemoglobin and Abnormal Hemoglobins
Practice Questions
Hemoglobin Synthesis
Practice Questions
Heme Synthesis and Porphyrias
Practice Questions
Iron Absorption and Transport
Practice Questions
Iron Storage and Recycling
Practice Questions
Disorders of Iron Metabolism
Practice Questions
Anemia: Biochemical Aspects
Practice Questions
Biochemistry of Hemostasis
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free